Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-11-25
pubmed:abstractText
In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1534-6080
pubmed:author
pubmed:issnType
Electronic
pubmed:day
27
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1194-202
pubmed:meshHeading
pubmed-meshheading:19935373-Adolescent, pubmed-meshheading:19935373-Adult, pubmed-meshheading:19935373-Aged, pubmed-meshheading:19935373-Confidence Intervals, pubmed-meshheading:19935373-Creatinine, pubmed-meshheading:19935373-Cyclosporine, pubmed-meshheading:19935373-Dose-Response Relationship, Drug, pubmed-meshheading:19935373-Drug Therapy, Combination, pubmed-meshheading:19935373-Humans, pubmed-meshheading:19935373-Immunosuppressive Agents, pubmed-meshheading:19935373-Kidney Transplantation, pubmed-meshheading:19935373-Living Donors, pubmed-meshheading:19935373-Middle Aged, pubmed-meshheading:19935373-Patient Compliance, pubmed-meshheading:19935373-Patient Selection, pubmed-meshheading:19935373-Sirolimus, pubmed-meshheading:19935373-Survival Analysis, pubmed-meshheading:19935373-Treatment Outcome, pubmed-meshheading:19935373-Triglycerides, pubmed-meshheading:19935373-Young Adult
pubmed:year
2009
pubmed:articleTitle
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.
pubmed:affiliation
Renal Transplant Unit, Careggi University Hospital, Florence, Italy. salvadorim@aou-careggi.toscana.it
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study